IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: Regulation of T helper 1/T helper 2 responses

György Haskó, Csaba Szabo

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

1. Interleukin-12 (IL-12) is a pivotal cytokine in driving the immune system towards a T helper (Th)1 type response and preventing a Th2 type immune profile. Therefore, IL-12 is indispensable in the defense against certain, mainly intracellular pathogens, but overproduction of this cytokine is crucially involved in the etiology of several inflammatory and autoimmune diseases. 2. Hence, IL-12 is an ideal target for pharmacological intervention in the therapy of autoimmune and inflammatory diseases. 3. The production of IL-12 and a resultant Th1 type immune response can be suppressed with several pharmacological approaches including modulation of intracellular cyclic AMP levels, glucocorticoids and nuclear factor-κB inhibition. IL-12 responsiveness may be inhibited using anti-IL-12 antibodies, soluble IL-12 receptors or the IL-12 p46 homodimer. 4. Exploitation of these approaches may provide novel means for the experimental therapy of a variety of pathophysiological states.

Original languageEnglish (US)
Pages (from-to)1295-1304
Number of pages10
JournalBritish Journal of Pharmacology
Volume127
Issue number6
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Interleukin-12
Pharmacology
Therapeutics
Autoimmune Diseases
Interleukin-12 Receptors
Cytokines
Investigational Therapies
Cyclic AMP
Glucocorticoids
Immune System
Antibodies

Keywords

  • Autoimmune disease
  • Catecholamine
  • Cytokines
  • Inflammation
  • Interferon-γ
  • Interleukin-10
  • Interleukin-2
  • Interleukin-4
  • Nitric oxide
  • Transcription factors

ASJC Scopus subject areas

  • Pharmacology

Cite this

IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases : Regulation of T helper 1/T helper 2 responses. / Haskó, György; Szabo, Csaba.

In: British Journal of Pharmacology, Vol. 127, No. 6, 1999, p. 1295-1304.

Research output: Contribution to journalArticle

@article{2f88930325104bc796b5d45727bdc933,
title = "IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: Regulation of T helper 1/T helper 2 responses",
abstract = "1. Interleukin-12 (IL-12) is a pivotal cytokine in driving the immune system towards a T helper (Th)1 type response and preventing a Th2 type immune profile. Therefore, IL-12 is indispensable in the defense against certain, mainly intracellular pathogens, but overproduction of this cytokine is crucially involved in the etiology of several inflammatory and autoimmune diseases. 2. Hence, IL-12 is an ideal target for pharmacological intervention in the therapy of autoimmune and inflammatory diseases. 3. The production of IL-12 and a resultant Th1 type immune response can be suppressed with several pharmacological approaches including modulation of intracellular cyclic AMP levels, glucocorticoids and nuclear factor-κB inhibition. IL-12 responsiveness may be inhibited using anti-IL-12 antibodies, soluble IL-12 receptors or the IL-12 p46 homodimer. 4. Exploitation of these approaches may provide novel means for the experimental therapy of a variety of pathophysiological states.",
keywords = "Autoimmune disease, Catecholamine, Cytokines, Inflammation, Interferon-γ, Interleukin-10, Interleukin-2, Interleukin-4, Nitric oxide, Transcription factors",
author = "Gy{\"o}rgy Hask{\'o} and Csaba Szabo",
year = "1999",
doi = "10.1038/sj.bjp.0702689",
language = "English (US)",
volume = "127",
pages = "1295--1304",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases

T2 - Regulation of T helper 1/T helper 2 responses

AU - Haskó, György

AU - Szabo, Csaba

PY - 1999

Y1 - 1999

N2 - 1. Interleukin-12 (IL-12) is a pivotal cytokine in driving the immune system towards a T helper (Th)1 type response and preventing a Th2 type immune profile. Therefore, IL-12 is indispensable in the defense against certain, mainly intracellular pathogens, but overproduction of this cytokine is crucially involved in the etiology of several inflammatory and autoimmune diseases. 2. Hence, IL-12 is an ideal target for pharmacological intervention in the therapy of autoimmune and inflammatory diseases. 3. The production of IL-12 and a resultant Th1 type immune response can be suppressed with several pharmacological approaches including modulation of intracellular cyclic AMP levels, glucocorticoids and nuclear factor-κB inhibition. IL-12 responsiveness may be inhibited using anti-IL-12 antibodies, soluble IL-12 receptors or the IL-12 p46 homodimer. 4. Exploitation of these approaches may provide novel means for the experimental therapy of a variety of pathophysiological states.

AB - 1. Interleukin-12 (IL-12) is a pivotal cytokine in driving the immune system towards a T helper (Th)1 type response and preventing a Th2 type immune profile. Therefore, IL-12 is indispensable in the defense against certain, mainly intracellular pathogens, but overproduction of this cytokine is crucially involved in the etiology of several inflammatory and autoimmune diseases. 2. Hence, IL-12 is an ideal target for pharmacological intervention in the therapy of autoimmune and inflammatory diseases. 3. The production of IL-12 and a resultant Th1 type immune response can be suppressed with several pharmacological approaches including modulation of intracellular cyclic AMP levels, glucocorticoids and nuclear factor-κB inhibition. IL-12 responsiveness may be inhibited using anti-IL-12 antibodies, soluble IL-12 receptors or the IL-12 p46 homodimer. 4. Exploitation of these approaches may provide novel means for the experimental therapy of a variety of pathophysiological states.

KW - Autoimmune disease

KW - Catecholamine

KW - Cytokines

KW - Inflammation

KW - Interferon-γ

KW - Interleukin-10

KW - Interleukin-2

KW - Interleukin-4

KW - Nitric oxide

KW - Transcription factors

UR - http://www.scopus.com/inward/record.url?scp=0032773289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032773289&partnerID=8YFLogxK

U2 - 10.1038/sj.bjp.0702689

DO - 10.1038/sj.bjp.0702689

M3 - Article

C2 - 10455278

AN - SCOPUS:0032773289

VL - 127

SP - 1295

EP - 1304

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 6

ER -